News

JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for…

2 years ago

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an…

2 years ago

Belite Bio Announces $25 Million Registered Direct Offering

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage…

2 years ago

Intuitive Announces Board of Directors Elections and Retirements

Lewis Chew elected to Intuitive’s BoardAlan Levy, PhD and Don Kania, PhD to retire from Board SUNNYVALE, Calif., April 25,…

2 years ago

Altimmune Statement on the Passing of Dr. Stephen Harrison

GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) -- The Altimmune team would like to express our sorrow and extend our…

2 years ago

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

Shenzhen, China, April 25, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),…

2 years ago

Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024

COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter…

2 years ago

Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World

10 Barrel Brewing Wins Innovation in Craft Brewing Award and Sweeps German-Style Sour Ale Category with Gold, Silver, and Bronze…

2 years ago

Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update

NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development…

2 years ago

Combined General Meeting of May 16, 2024

Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for…

2 years ago